<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <schemaVersion>X0202</schemaVersion>
<headerData>
    <submissionType>SCHEDULE 13G</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001572378</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <securitiesClassTitle>Common Stock, par value $0.00001 per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>09/30/2026</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0001745648</issuerCik>
        <issuerName>Apnimed, Inc.</issuerName>
        <issuerCusips>
          <issuerCusipNumber>03770Y107</issuerCusipNumber>
        </issuerCusips>
        <issuerPrincipalExecutiveOfficeAddress>
          <street1 xmlns="http://www.sec.gov/edgar/common">39 John F. Kennedy Street</street1>
          <street2 xmlns="http://www.sec.gov/edgar/common">4th Floor</street2>
          <city xmlns="http://www.sec.gov/edgar/common">Cambridge</city>
          <stateOrCountry xmlns="http://www.sec.gov/edgar/common">MA</stateOrCountry>
          <zipCode xmlns="http://www.sec.gov/edgar/common">02138</zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Miller Lawrence G.</reportingPersonName>
      <citizenshipOrOrganization>X1</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>2708263</soleVotingPower>
        <sharedVotingPower>0</sharedVotingPower>
        <soleDispositivePower>2708263</soleDispositivePower>
        <sharedDispositivePower>0</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>2708263</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>6.2</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>Apnimed, Inc.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>39 John F. Kennedy Street, 4th Floor, Cambridge, Massachusetts 02138</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed on behalf of Lawrence G. Miller, M.D. (the "Reporting Person").</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>c/o Apnimed, Inc., 39 John F. Kennedy Street, 4th Floor, Cambridge, Massachusetts 02138.</principalBusinessOfficeOrResidenceAddress>
        <citizenship>The Reporting Person is a citizen of the United States.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>The ownership information below represents beneficial ownership of Common Stock of the Issuer as of September 30, 2026, based upon 41,630,779 shares of Common Stock outstanding as of September 4, 2026, as disclosed by the Issuer in its Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on September 8, 2026, plus 2,249,171 shares of Common Stock underlying stock options held by the Reporting Person that are exercisable within 60 days of September 30, 2026, in accordance with Rule 13d-3(d)(1)(i). The Reporting Person may be deemed to be the beneficial owner of 2,708,263 shares of Common Stock, which includes: (i) 103,276 shares of Common Stock held of record by the Lawrence G. Miller Irrevocable Family Trust; (ii) 88,954 shares of Common Stock held of record by the Kathleen W. Miller Irrevocable Trust - 2022; (iii) 88,954 shares of Common Stock held of record by the James S. Miller Irrevocable Trust - 2022; (iv) 88,954 shares of Common Stock held of record by the David G. Miller Irrevocable Trust - 2022; (v) 88,954 shares of Common Stock held of record by the Ellen K. Williams Irrevocable Family Trust; and (vi) 2,249,171 shares of Common Stock underlying stock options exercisable within 60 days of September 30, 2026 by the Reporting Person.</amountBeneficiallyOwned>
        <classPercent>6.2%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>2,708,263</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>2,708,263</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Miller Lawrence G.</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Lawrence G. Miller</signature>
        <title>Lawrence G. Miller, M.D.</title>
        <date>11/16/2026</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
